Results 61 to 70 of about 5,983,769 (231)

Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy

open access: yesCancer Science, 2017
Inhibition of immune checkpoint molecules, PD‐1 and CTLA4, has been shown to be a promising cancer treatment. PD‐1 and CTLA4 inhibit TCR and co‐stimulatory signals.
S. Chikuma   +3 more
semanticscholar   +1 more source

The cytokine network in acute myeloid leukemia

open access: yesFrontiers in Immunology, 2022
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid disease progression.
Michela Luciano   +5 more
doaj   +1 more source

The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling [PDF]

open access: yes, 2008
The kinases MSK1 and MSK2 are activated 'downstream' of the p38 and Erk1/2 mitogen-activated protein kinases. Here we found that MSK1 and MSK2 were needed to limit the production of proinflammatory cytokines in response to stimulation of primary ...
A Cuenda   +61 more
core   +3 more sources

Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment

open access: yesFrontiers in Immunology, 2017
Suppressor of cytokine signaling (SOCS) proteins are major negative feedback regulators of cytokine signaling mediated by the Janus kinase (JAK)-signal transducer and activator of transcription signaling pathway. In particular, SOCS1 and SOCS3 are strong
Mengmeng Jiang   +5 more
semanticscholar   +1 more source

Features of cytokine signaling forming T-helper immune response in COPD of varying severity

open access: yesRussian Open Medical Journal, 2020
Introduction — Currently, chronic obstructive pulmonary disease (COPD) is a global public health problem. However, molecular mechanisms of the development of this pathology are still poorly understood.
Tatyana I. Vitkina   +1 more
doaj   +1 more source

Regulation of anti-inflammatory gene expression in vascular endothelial cells by EPAC1 [PDF]

open access: yes, 2015
Suppressor of cytokine signalling 3 (SOCS3) is a potent inhibitor of pro-inflammatory pathways involved in atherogenesis and the development of neo-intimal hyperplasia (NIH), which contributes to the in-stent re-stenosis responsible for the failure of ...
Palmer, Timothy P., Yarwood, Stephen J.
core   +1 more source

Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist

open access: yeseLife, 2021
Interleukin-2 is a pleiotropic cytokine that mediates both pro- and anti-inflammatory functions. Immune cells naturally differ in their sensitivity to IL-2 due to cell type and activation state-dependent expression of receptors and signaling pathway ...
Caleb R Glassman   +18 more
doaj   +1 more source

Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling

open access: yeseLife, 2017
Influenza virus infections have a significant impact on global human health. Individuals with suppressed immunity, or suffering from chronic inflammatory conditions such as COPD, are particularly susceptible to influenza.
L. Kedzierski   +21 more
semanticscholar   +1 more source

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

open access: yesSignal Transduction and Targeted Therapy, 2023
The Janus kinase (JAK) signal transducer and activator of transcription (JAK-STAT) pathway is an evolutionarily conserved mechanism of transmembrane signal transduction that enables cells to communicate with the exterior environment.
Chen Xue   +8 more
semanticscholar   +1 more source

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies. [PDF]

open access: yesPLoS ONE, 2016
Enhancement or inhibition of cytokine signaling and corresponding immune cells responses are critical factors in various disease treatments. Cytokine signaling may be inhibited by cytokine-neutralizing antibodies (CNAs), which prevents further activation
Boris Shulgin   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy